Osaic Holdings’s AbbVie ABBV Stock Holding History

Osaic Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-190	Closed	-$7.79K	–	7185
2023 Q4	$7.79K	Hold	190	–	–	﹤0.01%	5955
2023 Q3	$2.09K	Hold	190	–	–	﹤0.01%	6615
2023 Q2	$22.8K	Hold	190	–	–	﹤0.01%	5477
2023 Q1	$7.22K	Hold	190	–	–	﹤0.01%	6160
2022 Q4	$24K	Hold	190	–	–	﹤0.01%	5438
2022 Q3	$6K	Buy	+190	New	+$27.3K	﹤0.01%	6248
2022 Q2	–	Sell	-27	Closed	-$1K	–	7292
2022 Q1	$1K	Buy	+27	New	+$3.92K	﹤0.01%	6974
2021 Q4	–	Sell	-25	Closed	-$1K	–	7342
2021 Q3	$1K	Buy	+25	New	+$2.86K	﹤0.01%	6959
2021 Q1	–	Sell	-8	Closed	-$1K	–	6775
2020 Q4	$1K	Buy	+8	New	+$769	﹤0.01%	6160
2020 Q3	–	Sell	-6	Closed	-$1K	–	6172
2020 Q2	$1K	Hold	6	–	–	﹤0.01%	5888
2020 Q1	$2K	Buy	+6	New	+$511	﹤0.01%	5636

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Osaic Holdings's ABBV Position: Q1 2026 in Review

Osaic Holdings increased its AbbVie (ABBV) stake by 0.6% in Q1 2026, buying an estimated $956K and bringing the position to 726,921 shares worth $158M. The position accounts for 0.23% of the portfolio, ranked #75.

Osaic Holdings first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $180M in Q3 2023. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Osaic Holdings held 726,921 shares of AbbVie worth $158M as of Q1 2026.
Osaic Holdings bought 4,308 AbbVie shares in Q1 2026, an estimated $956K.
AbbVie made up 0.23% of Osaic Holdings's portfolio in Q1 2026, its #75 holding.
Osaic Holdings first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
Osaic Holdings's AbbVie position peaked at $180M in Q3 2023.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.